#United States #Guaynabo #Clinical Innovation #PharmPix #Dr. Martty

Dr. Martty Martínez Fraticelli's Groundbreaking Contributions to Pharmacy

In a significant recognition of excellence in the pharmacy benefit management sector, Dr. Martty Martínez Fraticelli, the President and CEO of PharmPix, has been awarded the 2026 PBMI Excellence Award for Clinical Innovation. This accolade, presented by the Pharmacy Benefit Management Institute (PBMI), acknowledges his transformative approach to pharmacy benefits, which emphasizes the integration of clinical intelligence into decision-making processes.

Dr. Martínez Fraticelli’s vision for PharmPix has always been centered around the idea that the accurate processing of a prescription does not necessarily equate to it being appropriate for the patient. This guiding principle aims to enhance the delivery of pharmacy benefits by identifying potential risks and unnecessary costs before they can escalate. Since co-founding PharmPix in 2009, he has worked tirelessly to position the organization as a leader in clinical-driven pharmacy management, fostering an environment where clinical insights inform every transaction.

At the heart of PharmPix's operational framework is the innovative technology platform, OneArk®. Developed by a team of experienced pharmacists and PBM operators, OneArk® serves as a comprehensive hub that integrates claims adjudication, clinical intelligence, benefit configuration, and real-time decision-making support. This integration allows PharmPix to not only evaluate claims but also actively identify and address potential drug-related issues—such as adverse drug interactions and inappropriate therapy selections—at the point of sale.

“Clinical innovation isn’t just about creating new technologies; it’s about utilizing existing tools effectively while also developing new solutions where there are gaps,” stated Dr. Martínez Fraticelli. His approach is to ensure that members are safeguarded against avoidable harm and that health plans are shielded from unnecessary expenses.

Furthermore, PharmPix’s holistic approach encompasses various aspects of clinical strategy, including medication safety, utilization management, specialty pharmacy services, and targeted programs addressing emerging clinical challenges. This comprehensive strategy aims not only to generate copious amounts of information but to convert that information into actionable strategies that lead to better healthcare decisions for both patients and healthcare plans.

Eric Frontera Zayas, Senior Vice President of PBM Services at PharmPix, noted Dr. Martínez Fraticelli’s influence on the organization’s philosophy: “It’s crucial that we ask not just whether we can pay a claim, but whether the therapy is safe, appropriate, and provides value.” This paradigm shift in decision-making processes resides at the core of PharmPix’s technological advancements and future growth initiatives.

The timing of this award aligns with the upcoming changes mandated by the Consolidated Appropriations Act of 2026, which will enhance transparency around pricing, rebates, and spending by PBMs. Dr. Martínez Fraticelli insists that while disclosure is a necessary first step, the more complex task involves translating this augmented visibility into direct clinical actions whenever prescriptions are filled. This aspect of his work encapsulates the essence of the PBMI Excellence Award.

On September 10, Dr. Martínez Fraticelli is scheduled to address participants at the PBMI conference, where he will delve into the emerging models of direct-to-consumer pharmacy and engage in critical discussions surrounding clinical accountability and patient safety. This forthcoming speech underscores his commitment to continuous improvement and innovation in the pharmacy benefit sector.

PharmPix operates as an independent, clinician-driven pharmacy benefit manager, committed to serving a diverse clientele that includes health plans, self-funded employers, and government programs. The company’s mission revolves around leveraging proprietary technology and in-depth clinical intelligence to minimize avoidable harm and costs, thereby allowing clients to see the full picture of pharmacy operations.

As Dr. Martínez Fraticelli continues to chart new territories in clinical innovation, his leadership not only elevates the standards within PharmPix but also sets a precedent for the future of pharmacy benefit management.